recombinant tetravalent HPV vaccine (Nanolek/Combiotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namerecombinant tetravalent HPV vaccine (Nanolek/Combiotech)
Drug Alias NameHPV tetravalent vaccine (Nanolek/)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNanolek Llc
China Registration ClassN/A

Develop Information

Active CompaniesCombiotechNanolek Llc
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A